# Addex Therapeutics Ltd.: Form 6-K, filed Sep 25, 2026

- Company: [Addex Therapeutics Ltd.](/companies/adxn.md) (CIK 1574232)
- Form: 6-K
- Filed: 2026-09-25
- Accepted by EDGAR: Sep 25, 2026, 06:05 ET
- Period: 2026-09-25
- Accession: 0001171843-26-006225
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1574232/000117184326006225/f6k_092526.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1574232/000117184326006225/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1574232/000117184326006225/f6k_092526.htm

Filed Sep 25, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-006225. Last ingested by Listed: Nov 14, 2026, 18:51 ET. No prices; not investment advice.
